NUEVOCOR
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
NUEVOCOR
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2020-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.nuevocor.com
Status:
Active
Total Funding:
24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Nuevocor
EDBI
EDBI investment in Series A - Nuevocor
EVX Ventures
EVX Ventures investment in Series A - Nuevocor
Xora Innovation
Xora Innovation investment in Series A - Nuevocor
Seeds Capital
Seeds Capital investment in Series A - Nuevocor
Official Site Inspections
http://www.nuevocor.com Semrush global rank: 6.26 M Semrush visits lastest month: 1.22 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Nuevocor"
Nuevocor | Treating Untreatable Genetic Cardiomyopathies
Sep 27, 2024 · At Nuevocor, our mission is to revolutionize the treatment of untreatable cardiomyopathies by embracing a mechanobiology-centered approach. These conditions …See details»
ABOUT US - Nuevocor
Nuevocor is a IND-stage biotech focused on treating genetic cardiomyopathies by addressing their underlying mechanical defects.See details»
SCIENCE | Nuevocor
Nuevocor is pioneering a functional approach where we leverage our PrOSIA platform to elucidate the disease mechanism and develop targeted therapies that treat the root cause of disease. …See details»
Nuevocor - Crunchbase Company Profile & Funding
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased …See details»
Nuevocor - LinkedIn
Nuevocor | 1,308 followers on LinkedIn. Pioneering novel therapies for untreatable cardiac diseases | Nuevocor, with offices in USA and Singapore, is developing genetic medicines for untreatable...See details»
Nuevocor Company Profile 2024: Valuation, Funding & Investors
Operator of a biotechnology firm intended to develop gene therapies for the treatment of cardiovascular disease. The company focuses on genetic cardiomyopathies characterized by …See details»
Delivering therapies to the heart's core - A*STAR …
Apr 7, 2022 · Nuevocor, an A*STAR spin-off company, is designing novel therapies to target the genetic causes of heart diseases, bringing basic research to clinical impact. When a cardiovascular disease diagnosis disrupts the ebb …See details»
Nuevocor presents pre-clinical data at ESGCT and AHA meetings
Nov 7, 2023 · At the ESGCT Congress on 24 – 27 October, 2023 in Brussels, Belgium, Nuevocor co-founder and Chief Executive Officer, Dr. Yann Chong Tan, presented a poster (P613) …See details»
Nuevocor - Biotech Careers
Headquartered in Singapore, Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac …See details»
Nuevocor - VentureRadar
Website: https://www.nuevocor.com/ Develops innovative gene therapies for genetic heart diseases, utilizing expertise in cardiac genetics, mechanobiology, and viral vector technology …See details»
Yann Chong Tan - Co-founder And Chief Executive Officer at …
Yann Chong Tan is currently the Co-founder and Chief Executive Officer at Nuevocor, and previously held the position of Co-founder and Chief Scientific Officer at Cargene …See details»
PIPELINE | Nuevocor
Nuevocor’s lead program NVC-001 treat patients suffering lamin-related dilated cardiomyopathy by addressing the biomechanical root cause of disease. Dilated cardiomyopathy is a common …See details»
Nuevocor: Tackling Untreatable Heart Conditions Through T-Up
Oct 1, 2024 · Founded in 2021, Nuevocor designs genetic medicines to treat incurable genetic cardiomyopathies - a gap in the health industry they noticed was not being addressed. …See details»
Nuevocor - Contacts, Employees, Board Members, Advisors
Nuevocor has 2 board members and advisors, including XiangQian (XQ) Lin. Nuevocor has 7 current employee profiles, including Co-Founder Colin Stewart. Nuevocor operates as a …See details»
Nuevocor closes US$24M Series A Financing to Advance Novel …
SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an …See details»
Nuevocor closes US$24M Series A Financing to Advance Novel …
SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an …See details»
Backed by Boehringer Ingelheim fund, Nuevocor snags $24M to …
Jun 18, 2021 · Nuevocor wants to restore cardiac function to diseased hearts through gene therapy and now has the backing of Boehringer Ingelheim through a $24 million series A. The …See details»
Nuevocor - Overview, News & Similar companies | ZoomInfo.com
Nov 12, 2013 · View Nuevocor (www.nuevocor.com) location in North East, Singapore , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Nuevocor to Present at ASGCT 2022 Meeting | Nuevocor
Apr 18, 2022 · Nuevocor, a pre-clinical stage cardiac gene therapy company, announced that it will present preclinical data on its adeno-associated virus (AAV) gene therapy for LMNA …See details»